,
your personalized virtual assistant to find clinical trials. Go head, 
Ingrid A Mayer
Vanderbilt-Ingram Cancer Center - Cool ...Nashville, Tennessee - 37064 (615-936-2033) Vanderbilt-Ingram Cancer CenterNashville, Tennessee - 37232 (615-936-1803) Vanderbilt UniversityNashville, Tennessee - 37232 (615-936-1767) Vanderbilt University Medical CenterNashville, Tennessee - 37232 |
- CLINICAL TRIALS 8
- CONDITIONS9
- INTERVENTIONS21
- SINCE2007
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
September 2009 - May 2015
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
March 2010 - November 2017
Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer
May 2010 - January 2017
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer
May 2007 - May 2010
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
January 2008 - January 2020
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
June 2009 - January 2017
Investigation of Genetic Determinants of Capecitabine Toxicity
November 2009 - April 2012
Cisplatin Paclitaxel and Everolimus in Treating Patients With Metastatic Breast Cancer
October 2009 - May 2015
Breast Neoplasms
Lung Neoplasms
Hypertension
Neoplasms
Ovarian Neoplasms
Head and Neck Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Colorectal Neoplasms
Placebo
Laboratory Biomarker Analysis
Questionnaire Administration
Assessment Of Therapy Complications
Paclitaxel
Bevacizumab
Cisplatin
Metformin Hydrochloride
Neoadjuvant Therapy
Therapeutic Conventional Surgery
Erlotinib
Goserelin
Everolimus
Trastuzumab
Lapatinib
Letrozole
Osi-906
Herceptin
Endocrine
Side-Effect Questionnaires
Research Blood Samples
